Market Overview

Benzinga's Top Upgrades

Related ADTN
ADTRAN to Enhance Shareholders' Wealth - Analyst Blog
ADTRAN Research Report Updated - Analyst Blog
Related MDT
St. Jude Medical Hits New Lifetime High - Analyst Blog
Deutsche Bank Reiterates On Medtronic And Covidien Amid Acquisition Proposal
In Pursuit of Shire, AbbVie Eyes Lower Taxes in UK (Fox Business)

Analysts at Citigroup upgraded ADTRAN (NASDAQ: ADTN) from “sell” to “neutral.” ADTRAN's stock closed at $21.96 yesterday. ADTRAN had $228.94 million in total cash for the latest quarter.

Credit Suisse upgraded Medtronic (NYSE: MDT) from “neutral” to “outperform.” Medtronic's shares closed at $43.94 yesterday. Medtronic's PEG ratio is 2.23.

Analysts at JP Morgan upgraded Juniper Networks (NYSE: JNPR) from “neutral” to “overweight.” Juniper's shares closed at $20.98 yesterday. Juniper's trailing-twelve-month revenue is $4.35 billion.

Macquarie upgraded Mercury General (NYSE: MCY) from “neutral” to “outperform.” Mercury General's shares closed at $39.17 yesterday. Mercury General's trailing-twelve-month operating margin is 10.10%.

Posted-In: top upgradesUpgrades Analyst Ratings


Most Popular

Related Articles (ADTN + JNPR)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free